Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions
Seminars in Thrombosis and Hemostasis · 01.11.2025 · 51 (08) · 941-949
DOI: 10.1055/a-2570-4538 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.11.2025. Verfasst von Mingyao Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Platelet Function Tests, Acute Coronary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Patients with high on-treatment platelet reactivity (HTPR) undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) face increased risks of major adverse cardiovascular events (MACEs). Although platelet function tests like thrombelastography (TEG), vasodilator-stimulated phosphoprotein (VASP), PL-11, and VerifyNow have been described, the correlation between them and their prognostic implications remains uncertain. This prospective study aims to evaluate the consistency and effectiveness of four platelet function detection methods in predicting long-term MACEs in patients with ACS. All 98 ACS patients undergoing PCI with clopidogrel were assessed for HTPR using four platelet function detection methods. The endpoint was the occurrence of MACEs, including cardiac death, nonfatal myocardial infarction (MI), and target vessel revascularization (TVR). Among 98 patients enrolled from April 1, 2014 to June 30, 2014, 27 (27.6%) patients with VerifyNow-detected HTPR (P2Y12 reaction units [PRUs] >240). The incidence of HTPR was 58.2% for TEG, 52% for VASP, and 13.3% for PL-11. VerifyNow and TEG showed the highest consistency in detecting HTPR (kappa = 0.201, p = 0.015). During a median follow-up of 6.1 years, 29 MACEs occurred, including 24 TVRs, 3 cardiovascular deaths, and 2 nonfatal MIs. VerifyNow-detected HTPR independently predicted long-term MACEs (hazard ratio: 5.73, 95% confidence interval: 2.04–16.09, p = 0.001), even after adjusting for traditional risk factors (TRFs). Receiver operating characteristic (ROC) analysis indicated that the model incorporating TRFs and VerifyNow-detected HTPR had superior predictive discrimination for MACEs (area under ROC curve = 0.889). VerifyNow-detected HTPR independently emerges as a robust predictor for long-term MACEs, demonstrating superior predictive discrimination compared with other platelet function tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China.
- Department of Cardiology, General Hospital of the PLA Central Theater Command, Wuhan, People's Republic of China.
- Department of Cardiology, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, People's Republic of China.
- Department of Cardiology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
- Department of Cardiology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Zitieren
APA
Zhou, M., Hou, P., Liang, Y., Tao, W., Guo, Z., Zhang, B., Lu, Y., Chu, G., & Li, P. (2025). Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions. Seminars in Thrombosis and Hemostasis, 51(08), 941-949. https://doi.org/10.1055/a-2570-4538
Vancouver
Zhou M, Hou P, Liang Y, Tao W, Guo Z, Zhang B, et al. Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions. Seminars in Thrombosis and Hemostasis. 2025;51(08):941-949. doi:10.1055/a-2570-4538
BibTeX
@article{Zhou2025,
author = {Zhou, Mingyao and Hou, Pan and Liang, Ying and Tao, Wenqi and Guo, Zhifu and Zhang, Bili and Lu, Yang and Chu, Guojun and Li, Pan},
title = {Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2025},
volume = {51},
number = {08},
pages = {941--949},
doi = {10.1055/a-2570-4538}
}
EUVIMED